Clinical Trial Update: Ozone Auto-hemotherapy for COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating ozone auto-hemotherapy for COVID-19 pneumonia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Ozone auto-hemotherapy

Snippet

Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | Conditions: COVID-19 Pneumonia | Phase 3 | Status: UNKNOWN